866-997-4948(US-Canada Toll Free)

Massachusetts General Hospital - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 26 Pages


Massachusetts General Hospital (MGH) is a pharmaceutical and health care service provider, based in the US. The company provides diagnostic and therapeutic care services including surgery. It provides treatment in the areas of allergy and immunology, orthopedics, neurology, hematology, neurology and neurosurgery, dermatology, endocrine disorders, diabetes, oncology, infectious diseases, pulmonary, oral and maxillofacial, renal, obstetrics and gynecology, arthritis and joint diseases and urology. The company also provides pediatric health care services through MassGeneral Hospital for Children. Its care centers include cancer center, critical care center, digestive health care center, heart center, transplant center and vascular center. MGH is headquartered in Boston, Massachusetts, the US.

This report is a source for data, analysis and actionable intelligence on the Massachusetts General Hospital portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3

Key Facts 4
Massachusetts General Hospital - Major Products and Services 5
Massachusetts General Hospital Pipeline Products by Equipment Type 6
Massachusetts General Hospital Pipeline Products by Development Stage 8
Massachusetts General Hospital Pipeline Products by Therapy Area 10
DMR Device 12
DMR Device Product Status 12
DMR Device Product Description 12
DMR Device - Ovarian Cancer 13
DMR Device - Ovarian Cancer Product Status 13
DMR Device - Ovarian Cancer Product Description 13
DMR Device - Tuberculosis 14
DMR Device - Tuberculosis Product Status 14
DMR Device - Tuberculosis Product Description 14
Nanomaterial - Cardiovascular Disease 15
Nanomaterial - Cardiovascular Disease Product Status 15
Nanomaterial - Cardiovascular Disease Product Description 15
Massachusetts General Hospital - Key Competitors 16
Massachusetts General Hospital - Key Employees 17
Massachusetts General Hospital - Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Massachusetts General Hospital, Recent Developments 19
Oct 18, 2012: Massachusetts General Hospital Receives $5.4m For Research To Guide Alzheimer\'s Drug Development 19
Sep 28, 2012: Ember Announces Cell Publication Of Key Data Showing TRPV4 Inhibition Activates Brown/Beige Fat And Protects Against Obesity, Inflammation And Insulin Resistance 19
Aug 02, 2012: Bachmann-Strauss Foundation Announces Two Grants Totaling $330,000 To Conduct Research On Dystonia 20
Jul 25, 2012: CT Angiography Speeds Emergency Diagnosis Of Heart Disease In Low-Risk Patients: New Study 20
Jun 14, 2012: Virtual Colonoscopy Without Laxative Equals Standard In Identifying Clinically Significant Polyps: University of California - San Francisco 21
May 14, 2012: Zeltiq Aesthetics Granted Preliminary Injunction In Infringement Case Against Clinipro In Spain 22
May 01, 2012: Decision Support System Translates Into High Percentage Of Positive Chest CT Examinations: American Roentgen Ray Society 23
Apr 30, 2012: Study Examines Benefit Of Follow-Up CT When Abdominal Ultrasound Inconclusive: American Roentgen Ray Society 23
Apr 19, 2012: Researchers Uncover New Genes Contributing To Autism And Related Neurodevelopmental Disorders 24
Apr 09, 2012: Normalizing Tumor Blood Vessels Improves Delivery Of Smallest Nanomedicines, Massachusetts General Hospital Study Reports 24

Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Table


Massachusetts General Hospital, Key Facts 1
Massachusetts General Hospital Key Pipeline Products by Equipment Type 1
Massachusetts General Hospital Key Pipeline Products by Therapy Area 1
Massachusetts General Hospital Key Pipeline Products by Development Stage 1
Massachusetts General Hospital, Key Facts 4
Massachusetts General Hospital, Major Products and Services 5
Massachusetts General Hospital Number of Pipeline Products by Equipment Type 6
Massachusetts General Hospital Pipeline Products by Equipment Type 7
Massachusetts General Hospital Number of Pipeline Products by Development Stage 8
Massachusetts General Hospital Pipeline Products by Development Stage 9
Massachusetts General Hospital Number of Pipeline Products by Therapy Area 10
Massachusetts General Hospital Pipeline Products by Therapy Area 11
DMR Device - Product Status 12
DMR Device - Product Description 12
DMR Device - Ovarian Cancer - Product Status 13
DMR Device - Ovarian Cancer - Product Description 13
DMR Device - Tuberculosis - Product Status 14
DMR Device - Tuberculosis - Product Description 14
Nanomaterial - Cardiovascular Disease - Product Status 15
Nanomaterial - Cardiovascular Disease - Product Description 15
Massachusetts General Hospital, Key Employees 17

List of Chart


Massachusetts General Hospital Key Pipeline Products by Equipment Type 1
Massachusetts General Hospital Pipeline Products by Equipment Type 6
Massachusetts General Hospital Pipeline Products by Development Stage 8
Massachusetts General Hospital Pipeline Products by Therapy Area 10

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *